Adjunct Professor Alison Todd and Dr Elisa Mokany have received the Prime Minister’s Prize for Innovation in the 2022 Prime Minister’s Prizes for Science. The pair are recognised for their...
SpeeDx Awarded REDI Fellowship to Support the development of Next Generation detection of Chlamydia trachomatis and Neisseria gonorrhoeae In collaboration with researchers at The University of Technology Sydney, focusing on...
Provision of SARS-CoV-2 tests reinforces PNG sovereign capacity to respond to ongoing pandemic. SpeeDx announce they have donated PlexPCR® SARS-CoV-2 tests and PlexPrime® SARS-CoV-2 Genotyping reagents to support Papua New Guinea...
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have added a new product to their portfolio; PlexMonkeypox* a single well, multiplex qPCR that simultaneously detects the Orthopoxvirus L1R...
The Australian Academy of Technological Sciences and Engineering (ATSE) has today launched a new industry internship program for STEM graduates, in partnership with leading Australian medical-tech, energy, intellectual property and...
Congratulations to the team at AMR Hub on your official launch. SpeeDx is thrilled to work alongside you in the fight against antimicrobial resistance. On 3 August 2022, the AMR Hub...
Collaboration with researchers at The University of Queensland aims to improve detection of antimicrobial resistant STI superbug The REDI Fellowship Program is part of MTPConnect’s $32 million Researcher Exchange and Development within Industry...
SYDNEY AUSTRALIA - December 1st, 2021, The NSW Minister for Health and Medical Research, the Honourable Brad Hazzard, attended the official launch of the SpeeDx facilities in the Australian Technology...
SYDNEY, AUSTRALIA - (October 27, 2021). SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have been awarded Australian Company of the Year, received in the 2021 AusBiotech and...
SpeeDx have further expanded their product line of research reagents for COVID-19 variant analysis to include a key characteristic mutation connected to the SARS-CoV-2 Lambda variant of interest (VOI). The...